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Generic, Simple Risk Stratification Model for Heart
Valve Surgery
Gareth Ambler, PhD; Rumana Z. Omar, PhD; Patrick Royston, DSc; Robin Kinsman, PhD;
Bruce E. Keogh, FRCS; Kenneth M. Taylor, FRCS
Background—Heart valve surgery has an associated in-hospital mortality rate of 4% to 8%. This study aims to develop
a simple risk model to predict the risk of in-hospital mortality for patients undergoing heart valve surgery to provide
information to patients and clinicians and to facilitate institutional comparisons.
Methods and Results—Data on 32 839 patients were obtained from the Society of Cardiothoracic Surgeons of Great
Britain and Ireland on patients who underwent heart valve surgery between April 1995 and March 2003. Data from the
first 5 years (n16 679) were used to develop the model; its performance was evaluated on the remaining data
(n16 160). The risk model presented here is based on the combined data. The overall in-hospital mortality was 6.4%.
The risk model included, in order of importance (all P0.01), operative priority, age, renal failure, operation sequence,
ejection fraction, concomitant tricuspid valve surgery, type of valve operation, concomitant CABG surgery, body mass
index, preoperative arrhythmias, diabetes, gender, and hypertension. The risk model exhibited good predictive ability
(Hosmer-Lemeshow test, P0.78) and discriminated between high- and low-risk patients reasonably well (receiver-
operating characteristics curve area, 0.77).
Conclusions—This is the first risk model that predicts in-hospital mortality for aortic and/or mitral heart valve patients with
or without concomitant CABG. Based on a large national database of heart valve patients, this model has been evaluated
successfully on patients who had valve surgery during a subsequent time period. It is simple to use, includes routinely
collected variables, and provides a useful tool for patient advice and institutional comparisons. (Circulation. 2005;112:
224-231.)
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The profile of cardiac surgical practice is changing. Thenumber of patients undergoing CABG surgery is static or
falling in the United Kingdom, whereas the proportion and
number of patients requiring surgery for valvular heart
disease is increasing.1 Approximately 275 000 heart valve
operations are carried out annually worldwide,2 with 9000
carried out in the United Kingdom alone.1 Heart valve
surgery has an associated short-term mortality of 4% to 8%,
which is at least twice that of CABG surgery in the United
Kingdom, United States, and Europe.1,3–6 The growth in
valve surgery, higher operative mortality, and increased
public, political, and professional interest in comparative
outcome measures have encouraged us to explore a model
based on UK data.
Over the last 2 decades, several risk models have been
proposed to predict the risk of short-term mortality after
cardiac surgery on the basis of the patients’ preoperative
characteristics.7–10 However, most of these models have been
developed for CABG surgery. Although some studies have
investigated potential predictors of short-term mortality after
heart valve surgery,3,11–13 there are few risk models specifi-
cally for heart valve patients.4,6,14 We propose a simple,
generic risk model that may be used to predict in-hospital
mortality for patients undergoing heart valve surgery with or
without concomitant CABG surgery. The aims of the risk
model are to provide information to clinicians and patients
about the risk of in-hospital mortality after surgery and to
facilitate a fairer comparison of institutional performance.
Methods
Protocol Preparation
Before starting the modeling process, we prepared a protocol that
outlined the various steps to be undertaken in developing and
validating the model. The protocol specified the clinical aims of the
risk model, a list of potential predictors for in-hospital mortality,
exclusion criteria for patients, and all statistical methods to be used.
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Patients
All patients in the database of the Society of Cardiothoracic
Surgeons of Great Britain and Ireland (SCTS) who underwent aortic
and/or mitral heart valve surgery, both repair and replacement, from
April 1995 to March 2003 were considered for inclusion. Because
valvular disorders more commonly affect the aortic and mitral
valves,15 we did not consider patients who had only pulmonary
and/or tricuspid valve surgery to avoid computational problems
associated with small numbers. Salvage patients also were not
considered. The clinical outcome considered was in-hospital mortal-
ity, defined as the patient’s status at discharge after the operation.
The procedures used to collect these data are described in SCTS
reports.1 Briefly, these data are supplied by participating centers and
are subject to internal data consistency checks. Additionally, 10% of
case notes for patients undergoing coronary surgery were subject to
independent scrutiny.16 This scrutiny revealed accurate reporting of
in-hospital deaths and good correlation between case note risk
factors and those recorded in the database, with both completeness
and accuracy improving over time. More recently, the vital status of
16 000 patients undergoing valve and/or coronary surgery was
obtained from the Office of National Statistics. We found that the
outcome status (dead or alive) of only 2 patients was coded
inaccurately.
The following preoperative patient characteristics were chosen in
advance as candidate predictors from clinical knowledge and previ-
ous research3,4,11–13: age, gender, body mass index (BMI), number
and position of implanted heart valves, hypertension (no/yes; treated
or blood pressure 140/90 mm Hg), diabetes (no/yes; managed by
diet, oral therapy, or insulin), renal failure (none or functioning
transplant/creatinine 200 moL/dialysis dependency), respiratory
disease (no/chronic obstructive pulmonary disease), ejection fraction
(30%/30% to 50%/50%), arrhythmias (no/atrial fibrillation or
heart block/ventricular tachycardia or fibrillation), active endocardi-
tis (no/yes), operative priority (elective/urgent/emergency), opera-
tion sequence (previous sternotomy; first/second/third or more),
concomitant CABG surgery (no/yes), concomitant tricuspid surgery
(no/yes), valve regurgitation or stenosis (no/yes), left ventricular
end-diastolic pressure and pulmonary artery wedge pressure, and
aortic valve gradient.
The categorization used for ejection fraction, creatinine level, and
blood pressure were based on the coding used by the SCTS.
We split the data into development (training) and validation (test)
data sets. The development data included all operations within the
first 5 years; the validation data included the rest. To ensure
reliability of data, we excluded patients who had missing information
on key predictors: age, gender, operation sequence, and number and
position of implanted heart valves. In addition, patients were
excluded from the development data if they were missing informa-
tion on 3 of the remaining predictors. Any predictor recorded for
50% of patients in the development data was not included in the
modeling process, resulting in the exclusion of left ventricular
end-diastolic pressure, pulmonary artery wedge pressure, aortic
valve gradient, and active endocarditis. Patients were excluded from
the validation data if they had missing information on any of the
predictors in the risk model.
We initially developed a single risk model for both aortic and
mitral valve surgery because it would be easier to apply in practice.
To investigate whether the importance of particular predictors varied
by type of operation, we compared this model with separate
valve-specific risk models. The latter also included valve-specific
factors, regurgitation, and stenosis.
Model Development
To investigate whether exclusions of patients as a result of missing
data had introduced any bias, we compared the key preoperative
characteristics of patients excluded from the study with those
included. Any remaining missing predictor values in the develop-
ment data were imputed by use of multiple imputation tech-
niques.17,18 Five different imputed data sets were created.
We developed the risk model using a logistic regression model
fitted with generalized estimating equations (GEE) methodology19 to
adjust for clustering of patients within institutions.20 An exchange-
able correlation structure was used to apply the GEE methodology.
This methodology assumes that pairwise correlations between pa-
tients within the same institution are equal, whereas patients from
different institutions are independent. The logistic model was fitted
to each of the 5 imputed data sets, and the 5 sets of results were
combined to give overall regression coefficients and confidence
intervals.17
We selected the predictors for the risk model using a backwards
elimination strategy21 with a statistical significance level of 5%. We
included year of surgery in the model to adjust for changes that may
occur in in-hospital mortality over the 5-year period in the develop-
ment data. Fractional polynomials were used to explore presence of
nonlinear relationships of the continuous predictors of age, BMI, and
year to outcome and to suggest possible categorization of these
predictors.22
We converted the regression coefficients to integer scores to make
the risk model easier to use in practice. The scale factor required for
this transformation was found via a grid search so that as much of the
predictive accuracy of the original logistic model was retained. We
assessed this by calculating the correlation between the predicted log
odds from the original and simplified models (risk score). We
performed the goodness of fit and validation exercises using the risk
scores, with the year effect adjusted for the latest year in the
development data (2000).
The goodness of fit of the model in the development data was
assessed with the Hosmer-Lemeshow (H-L) test.23 This assesses the
agreement between observed and predicted mortality typically within
10 equal-sized groups (deciles) based on the predicted risk of
mortality. We plotted the observed and predicted log odds in these
groups to ascertain whether the risk model predicted mortality
correctly.
Model Validation
We adopted an external validation approach21 to evaluate the perfor-
mance of the model and used the H-L test to assess the agreement
between the observed and predicted mortality in the validation data. We
used clinically relevant risk groups based on predicted mortality defined
by the cut points of 2.5%, 5%, 10%, and 20% used in other studies.3,24
Accurate predictions of mortality within each of these risk groups would
suggest that the risk model is suitable for use for patient advice for all
(low- to high-risk) patients.
We also investigated the agreement between the total observed
and predicted mortality within each institution in the validation data.
For each institution, we predicted the number of deaths from the risk
model, and using the binomial distribution, we constructed an
interval within which we would expect the observed number of
deaths to lie 95% of the time. We then considered whether the
observed number of deaths lay within this interval.
The receiver-operating characteristics (ROC) curve area was used
as a measure of how well the model discriminated between patients
with high and low risks of mortality.25 A reasonably high ROC area
suggests that the model may be used to rank patients into treatment
groups to facilitate treatment management.
Risk Model
The final step, after a successful validation exercise, was to combine
the development and validation data, refit the logistic risk model
using all the data, and derive the final risk score.21 The risk score is
presented for the latest year in the combined data (2003); no
adjustment should be necessary for patients who had surgery at
subsequent time periods.
All statistical analyses were carried out with the STATA statistical
software.26
Results
Characteristics
Initially, our data set consisted of 42 052 patients. However,
2724 patients were excluded from the development data
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because they were missing 1 key predictors, with another
1476 patients excluded because they had 3 predictors
missing. In total, 5013 patients were excluded from the
validation data because they were missing information on
predictors in the proposed risk model. The final study sample
comprised of 32 839 patients from 30 institutions. The
excluded patients had an overall in-hospital mortality of 6.9%
and a mean age of 65.5 years (SD, 12.5 years), 40.7% were
female, and 63.9% and 29.6% had isolated aortic and isolated
mitral valve operations, respectively. The included patients
had 6.4% mortality and a mean age of 64.8 years (SD, 12.3
years), 41.6% were female, and 64.4% and 29.4% had
isolated aortic and isolated mitral valve operations. These
values suggest that our exclusion criteria have not caused any
important clinical bias.
The proportion of patients by valve operation and the
associated mortality are presented in Table 1. A total of 2089
deaths (6.4%) were observed. Aortic valve surgery was more
common and was associated with a lower crude mortality
than mitral valve surgery. About 2% of the patients had
concomitant tricuspid valve procedure at the time of aortic
and/or mitral valve surgery, and a very small percentage
(0.5%) of patients had concomitant pulmonary valve surgery.
The development and validation data have a similar break-
down by types of valve surgery, but there is lower overall
mortality in the validation data. This could be due partly to
improvements in surgical procedure and postoperative care
over the time period studied.
The preoperative characteristics (predictors) of the patients
are summarized in Table 2. The patients in the 2 data sets are
similar, although hypertension and high BMI are more
prevalent in the validation data and high creatinine levels are
more prevalent in the development data. Table 2 also shows
the percentage missing for each predictor. The 3 predictors
that required the most imputation in the development data
were arrhythmias (32.3% missing) and renal (14.1%) and
respiratory (11.8%) disease.
Model Development
Respiratory diseases was the only predictor dropped by the
backward elimination algorithm (P0.35). The odds ratios
(ORs) for the remaining predictors are shown in Table 3.
Rounding the regression coefficients to integer scores re-
sulted in little loss of predictive accuracy; the correlation
between the predicted log odds before and after the simplifi-
cation exceeded 0.99. However, the H-L test suggested that
the risk model did not fit the development data well
(P0.001; Figure 1a); it overpredicted risk of mortality for
the low-risk patients and underpredicted mortality for the
higher-risk group. Therefore, the model was recalibrated by
considering possible transformations for the predicted log
odds; an exponential function was found to be appropriate.
This recalibration greatly improved the fit of the model (HL
test, P0.59; Figure 1b).
Model Validation
A more stringent validation exercise was performed by
examining the ability of the model to make accurate predic-
tions for a subsequent group of patients not used for its
development. The risk model predicted mortality in the
validation data accurately (Table 4), despite the lower ob-
served mortality (Table 1). Additionally, the model predicted
mortality well within each clinical risk group (H-L test,
P0.78; Table 4).
A plot of the total observed and predicted mortality is
shown for the institutions in Figure 2, with 95% intervals
placed around the predicted values. There are fewer institu-
tions because the risk model could not be applied to 5 of the
institutions: One did not contribute validation data and 4 had
missing information on arrhythmias. The plot shows that
observed mortality lies within the range predicted by the
model for 18 of the 25 institutions. This type of plot may be
used to identify institutions with unexpectedly low or high
mortality, perhaps caused by unmeasured patient or institu-
tional characteristics.
The area under the ROC curve was 0.77 (95% CI, 0.76 to
0.79), which suggests that the risk model has reasonable
discriminatory ability and may be used to stratify patients into
risk groups for treatment management.
To examine whether a single risk model is appropriate for
patients undergoing different types of valve operations listed
in Table 1, we examined the performance of the model for
patients divided into subgroups according to their operation
type. The aortic and mitral patients, with and without CABG,
were combined to avoid problems with small numbers. We
used the same clinical risk groups as before but combined the
2 higher-risk groups to avoid problems with small numbers.
Figure 3 demonstrates good agreement between the observed
and predicted mortality for patients for all operation types,
suggesting that a single risk model is appropriate. The H-L
test results and ROC areas (Table 5) also suggest good
calibration and reasonable discrimination.
We also investigated whether the model was suitable for
both patients who had had previous cardiac surgery and those
who had not. The plots of observed and predicted mortality
(Figure 4) and the corresponding H-L test values (Table 5)
suggest that the model works very well for both groups of
patients.
Risk Model
We then refitted the risk model after combining the develop-
ment and validation data, derived risk scores (Table 6), and
recalibrated the risk model. The highest risk scores were
TABLE 1. In-Hospital Mortality by Type of Valve Surgery for
Development and Validation Data
Operative Category
Development, %
(% mortality)
(n16 679)
Validation, %
(% mortality)
(n16 160)
Aortic valve 42.0 (4.9) 39.9 (3.7)
Mitral valve 21.3 (7.1) 20.1 (5.1)
Aortic and mitral 4.7 (11.0) 5.1 (8.6)
Aortic valveCABG 22.2 (7.9) 24.6 (7.1)
Mitral valveCABG 8.6 (11.7) 8.8 (9.2)
Aortic and mitralCABG 1.2 (12.8) 1.5 (15.5)
Overall 100.0 (7.0) 100.0 (5.7)
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associated with emergency priority, followed by age 79
years, renal failure with dialysis, and 2 previous cardiac
operations.
The total risk score for a patient can be related to the probability
of death through the use of a lookup table (Table 7) or the following
relationships: log odds1.361.75exp(1.450.0716S), and
risk of in-hospital death (%)100/[1exp(log odds)], where S is
the sum of the risk scores for an individual patient.
Investigation of Additional Predictors
Active endocarditis has been observed to be an important risk
factor of mortality in some studies.4,11 Following our proto-
col, we excluded active endocarditis because information on
this factor was missing for 50% of patients. We did
investigate, however, whether it had important prognostic
value by developing a risk model using just those patients for
whom it had been measured (n9257). The predictor was
statistically significant (P0.001), but the OR of 1.73 (95%
CI, 1.45 to 2.07) does not classify active endocarditis as one
of the stronger predictors (see Table 3). Furthermore, this risk
model does not provide improved performance in the valida-
tion data as assessed by the ROC area and H-L test.
We also investigated whether the presence of stenosis or
regurgitation is associated with mortality using valve-specific
models. We developed 2 separate models for isolated aortic
and isolated mitral valve patients for whom regurgitation and
stenosis information was available. The predictor represent-
ing stenosis and/or regurgitation was not statistically signif-
icant for either aortic patients (P0.15) or mitral patients
(P0.48). These results agree with the findings of other
TABLE 2. In-Hospital Mortality by Preoperative Characteristics
and Development and Validation Data
Predictor
Development, %
(% mortality)
(n16 679)
Validation, %
(% mortality)
(n16 160)
Age, y
50 11.0 (3.9) 10.6 (2.6)
50–59 17.0 (4.5) 14.8 (3.7)
60–69 33.2 (6.2) 31.2 (4.9)
70–79 33.3 (9.3) 35.8 (7.4)
79 5.5 (11.2) 7.6 (9.7)
Gender
Male 58.3 (6.3) 58.3 (5.1)
Female 41.7 (7.9) 41.5 (6.6)
BMI, kg/m2
Underweight (20) 10.0 (10.5) 6.5 (10.4)
Normal (20–25) 36.8 (7.5) 34.8 (6.3)
Overweight (25) 48.7 (5.8) 58.8 (4.9)
(Missing) 4.6 (7.6)   
Respiratory disease
No 83.7 (6.7) 91.4 (5.4)
COPD 4.6 (9.2) 8.6 (8.8)
(Missing) 11.8 (8.0)   
Renal failure
No* 79.6 (5.5) 97.3 (5.2)
High creatinine† 5.7 (19.0) 1.9 (24.3)
Dialysis 0.7 (26.8) 0.7 (27.5)
(Missing) 14.1 (9.4)   
Preoperative arrhythmias
No 43.9 (4.1) 75.3 (5.0)
AF/heart block 21.6 (10.0) 24.3 (7.9)
VT/VF 2.3 (8.5) 0.4 (14.9)
(Missing) 32.3 (8.8)   
Hypertension
No 68.2 (6.5) 57.9 (5.2)
Yes 30.5 (8.0) 42.1 (6.5)
(Missing) 1.3 (10.6)   
Diabetes
No 91.1 (6.6) 90.4 (5.4)
Yes 7.6 (11.2) 9.6 (9.0)
(Missing) 1.3 (6.8)   
Ejection fraction
Good (50%) 59.0 (5.5) 68.0 (4.1)
Fair (30%–50%) 25.5 (8.5) 25.5 (7.4)
Poor (30%) 6.4 (16.5) 6.5 (16.1)
(Missing) 9.1 (5.2)   
Priority
Elective 70.4 (5.0) 74.9 (3.7)
Urgent 24.4 (9.4) 21.1 (9.8)
Emergency 4.5 (24.5) 4.0 (22.2)
(Missing) 0.7 (11.3)   
TABLE 2. Continued
Predictor
Development, %
(% mortality)
(n16 679)
Validation, %
(% mortality)
(n16 160)
Concomitant tricuspid surgery
No 98.2 (6.8) 97.4 (5.5)
Yes 1.8 (18.6) 2.6 (14.4)
Operation sequence
First operation 85.9 (6.2) 88.8 (5.0)
Second operation 12.0 (10.7) 9.4 (11.3)
Third or more 2.1 (17.1) 1.8 (12.9)
Year of operation
1995 6.2 (8.9)   
1996 11.2 (7.9)   
1997 17.3 (7.8)   
1998 23.9 (6.8)   
1999 32.1 (6.1)   
2000 9.2 (6.5) 21.7 (6.2)
2001    32.0 (6.2)
2002    36.8 (5.1)
2003    9.4 (5.3)
COPD indicates chronic obstructive pulmonary disease; AF, atrial fibrillation;
and VT/VF, ventricular tachycardia/ventricular fibrillation.
*Includes functioning transplant.
†Creatinine 200 mol/L.
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authors.6 Additionally, the valve-specific models did not offer
any improvement in performance compared with the single
model.
Discussion
Heart valve surgery is the second-most-common type of
cardiac surgery, accounting for 20% to 35% of all cardiac
surgical procedures, with an in-hospital mortality of 4% to
8%.1,3–6 Although several studies have investigated potential
predictors of short-term mortality after heart valve sur-
gery,3,11–13 there are few risk models specifically for heart
valve patients that present all the information necessary for
use in health institutions.4,6,14
Nowicki and colleagues6 used 8943 patients from 8 New
England medical centers to derive separate risk models for
in-hospital mortality after isolated aortic valve and isolated
mitral valve surgery and provided simplified risk scores
complete with a lookup table. These models cannot be
applied to patients undergoing multiple valve surgery. The
models were validated on data used for their development;
thus, it is unclear how well the risk models will perform in
independent data or how accurate the simplified risk scores
are compared with the original logistic models.
Edwards and colleagues4 derived 2 risk models, one for
isolated valve surgery and one for valve surgery plus CABG.
Their outcome included in-hospital mortality and 30-day
mortality if the patient had been discharged. Single imputa-
Figure 1. Observed and predicted log odds of mortality in
development data.
TABLE 3. ORs for Predictors in the Logistic Model
Predictor OR (95% CI)
Age, y
50 1 (  )
50–59 1.10 (0.78–1.54)
60–69 1.52 (1.11–2.10)
70–79 2.22 (1.60–3.07)
79 2.92 (2.00–4.28)
Gender
Male 1 (  )
Female 1.22 (1.09–1.37)
BMI, kg/m2
Underweight (20) 1.42 (1.18–1.71)
Normal (20–25) 1 (  )
Overweight (25) 0.90 (0.78–1.05)
Concomitant CABG surgery
No 1 (  )
Yes 1.54 (1.35–1.76)
Valve operation
Aortic 1 (  )
Mitral 1.27 (1.09–1.48)
Aortic and mitral 1.72 (1.25–2.36)
Concomitant tricuspid surgery
No 1 (  )
Yes 1.94 (1.39–2.71)
Renal failure
No* 1 (  )
High creatinine† 1.89 (1.50–2.38)
Dialysis 3.00 (1.68–5.35)
Preoperative arrhythmias
No 1 (  )
AF/heart block 1.58 (1.31–1.90)
VT/VF 1.48 (1.00–2.20)
Hypertension
No 1 (  )
Yes 1.32 (1.18–1.47)
Diabetes
No 1 (  )
Yes 1.30 (1.06–1.59)
Ejection fraction
Good (50%) 1 (  )
Fair (30%–50%) 1.20 (1.04–1.39)
Poor (30%) 1.99 (1.64–2.41)
Priority of surgery
Elective 1 (  )
Urgent 1.63 (1.39–1.90)
Emergency 4.87 (3.78–6.26)
Operation sequence
First operation 1 (  )
Second operation 1.73 (1.53–1.96)
Third or more 2.80 (2.02–3.87)
Year
Per year 0.95 (0.89–1.02)
Abbreviations as in Table 1.
*Includes functioning transplant.
†Creatinine 200 mol/L.
TABLE 4. Observed and Predicted Mortality Within Clinical
Risk Groups
Risk Group
Patients,
n
Observed
Mortality,
n (%)
Predicted
Mortality,
n (%)
2.5% 6020 80 (1.3) 84.3 (1.4)
2.5% to 5.0% 3594 129 (3.6) 134.9 (3.8)
5% to 10% 4056 283 (7.0) 287.0 (7.1)
10% to 20% 1922 260 (13.5) 272.3 (14.2)
20% 568 174 (30.6) 161.7 (28.5)
Total 16 160 926 (5.7) 940.3 (5.8)
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tion methods were used to handle missing data. This risk
model is not in the public domain because the authors do not
present all the information necessary to calculate the risk of
death for a patient. Again, these models cannot be applied to
patients undergoing multiple valve surgery.
Florath and colleagues,14 using 1400 patients from one
institution in Germany, have developed a risk model for
30-day mortality after aortic valve surgery. The model also
allows for concomitant CABG and mitral valve surgery.
However the risk model was developed on a small data set,
which may lead to overfitting.21 Because the authors per-
formed internal validation only, it is unclear how well the risk
model will perform in independent data.
The aim of our work was to develop a single, simple risk
model for heart valve patients that can be used to predict
in-hospital mortality and facilitate better informed consent
and fairer comparisons of institutional performance. We used
a large national database consisting of 30 institutions (SCTS)
and 32 502 patients to develop and validate the risk model.
We took into account the hierarchical nature of the data—
ie, patients clustered within institutions—by using logistic
models based on GEE. The results proved to be somewhat
different from those obtained with ordinary logistic regres-
sion, indicating that the correlation between patients within
an institution should not be ignored in the modeling process.
Shahian and colleagues20 have previously suggested that risk
modeling should incorporate the appropriate hierarchical
nature to obtain correct statistical inferences.
Missing data were handled by use of multiple imputation
techniques.17,18 This method allows the use of far more data
than would be permitted through a complete case analysis and
is superior to single imputation techniques.18
Our single risk model can be applied to patients undergo-
ing aortic valve surgery, mitral valve surgery, or both, with or
without concomitant CABG surgery. A single, generic model
for all valves is arguably more useful because many institu-
tions perform relatively small numbers of valve procedures.
The validation results suggest that our single model is
suitable for different types of operation.
Our proposed risk model identified age, BMI, gender, site
of valve surgery, concomitant CABG and tricuspid valve
surgery, renal failure, diabetes, hypertension, poor ejection
fraction, arrhythmias, number of previous cardiac operations,
and priority of surgery as important predictors of in-hospital
mortality. The strongest predictors were operative priority,
followed by renal failure, age, and operation sequence. These
findings are supported by previous studies.3,4,6,11–13
Our risk model contains relatively few preoperative pre-
dictors,13 all of which are routinely collected in most institu-
Figure 2. Total observed and predicted mortality by institution.
Figure 3. Observed and predicted mortality by type of
operation.
TABLE 5. H-L Test Probability Values and ROC Area From Patient Subgroups
Subgroup Patients, n Deaths, n H-L P ROC Area (95% CI)
Aortic 6452 240 0.74 0.77 (0.74–0.79)
Mitral 3254 167 0.09 0.81 (0.78–0.84)
AorticCABG 3975 281 0.49 0.73 (0.70–0.77)
MitralCABG 1419 130 0.61 0.71 (0.67–0.76)
Aorticmitral with or without CABG 1060 108 0.73 0.72 (0.67–0.76)
No previous operation 14 350 717 0.97 0.76 (0.75–0.78)
Previous operation 1810 209 0.99 0.74 (0.71–0.78)
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tions in a reliable manner. Including more predictors may
limit the applicability of a risk model, particularly in institu-
tions in which resources to collect such data are limited.
Some approaches could be adopted even if these predictors
were missing for some patients. One would be to calculate a
range containing the minimum and maximum risks for a
patient by assuming the 2 extreme possibilities for a missing
predictor value. For example, if a patient is missing informa-
tion on priority, we could obtain lower and higher risk
estimates by assuming “elective” and “emergency,” respec-
tively. If we simply assume that the missing value is the most
popular category, we will typically underestimate the risk.
Active endocarditis was found to have a statistically
significant association with in-hospital mortality. It was
excluded from the model because this predictor is collected in
50% of institutions in the United Kingdom. Inclusion of
this predictor would immediately limit wider application of
the model. Furthermore, active infective endocarditis is a
relatively uncommon pathology, responsible for only 4% of
valve operations.5 Some elements of the increased risk are
likely to be picked up by the weightings for surgical priority,
arrhythmias, and renal failure. Our investigation with this
predictor suggests that, despite its statistical significance, it
may not provide much improvement in model performance.
The data consisted of operations performed over an 8-year
period. Consequently, we adjusted for year of operation in
our model to allow for possible differences in in-hospital
mortality resulting from changes in surgical procedures and
patient care over time. This is an approach taken by others.6
Figure 4. Observed and predicted mortality by operation
sequence.
TABLE 6. Risk Model
Preoperative Characteristic Score
Age, y
50–59 1
60–69 2
70–79 4
79 5
Female gender 1
BMI 20 kg/m2 2
Valve operation
Mitral 1
Aortic and mitral 2
Concomitant tricuspid surgery 3
Concomitant CABG surgery 2
Renal failure
Creatinine 200 mol/L 3
With dialysis 5
Arrhythmias
Atrial fibrillation/heart block 1
Ventricular tachycardia/fibrillation 2
Hypertension 1
Diabetes 1
Ejection fraction, %
30–50 1
30 4
Surgical priority
Urgent 2
Emergency 7
Prior cardiac operation
1 3
2 4
TABLE 7. Mortality Risk by Total Risk Score
Total Risk Score Risk, %
0 0.2
1 0.4
2 0.6
3 1.0
4 1.4
5 2.1
6 3.0
7 4.1
8 5.5
9 7.3
10 9.3
11 11.7
12 14.3
13 17.2
14 20.2
15 23.5
16 26.7
17 30.1
18 33.4
19 36.6
20 39.7
21 42.6
22 45.5
23 48.1
24 50.6
25 52.9
Risk percentages are weighted for year 2003 on.
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The risk score and lookup table (Tables 6 and 7) are presented
for the latest year in our data (2003) and should be appropri-
ate for operations performed after this date, as suggested by
our validation exercise. However, we suggest that all pro-
posed risk models have a “use-by date” and perhaps be
updated every few years, depending on clinical issues and
statistical performance.
We have used data from the Great Britain and Ireland
national cardiac surgical database, which is the best source of
information on predictors for heart valve patients from the
United Kingdom. However, the database was not designed
specifically for the derivation of heart valve risk models, and
the data were supplied voluntarily by institutions. Conse-
quently, we are missing information on a few valve-specific
predictors. We had to rely on the internal data collecting
procedures used by the individual institutions; however, by
excluding patients with missing values for key predictors and
those with several predictors missing, we have attempted to
provide some quality control for the data.
We performed temporal validation to assess the perfor-
mance of the risk model, developing the risk model on early
data and validating it on later data. This type of validation
exercise, described as external by Harrell,21 is more stringent
than randomly splitting the data into development and vali-
dation data sets.21 However, a more stringent test is to
perform external validation using completely new data from
other institutions to further assess the generalizability of the
proposed model. We encourage other researchers to do this.
The risk model proposed here provides a simple, useful
tool for risk stratification for most patients undergoing valve
surgery.
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